S&P 500   4,596.29 (-1.27%)
DOW   34,662.39 (-1.35%)
QQQ   394.40 (-1.32%)
AAPL   163.91 (+2.29%)
MSFT   331.43 (-1.54%)
FB   327.70 (-3.06%)
GOOGL   2,853.08 (-1.98%)
AMZN   3,514.53 (-1.32%)
TSLA   1,135.88 (-0.10%)
NVDA   323.96 (-2.94%)
BABA   127.48 (-3.14%)
NIO   39.14 (-3.26%)
CGC   10.48 (-5.24%)
AMD   157.48 (-2.74%)
GE   95.40 (-3.05%)
MU   85.01 (-1.31%)
T   22.68 (-5.06%)
F   19.24 (-2.19%)
DIS   144.18 (-2.46%)
ACB   6.24 (-3.11%)
AMC   34.13 (-7.36%)
PFE   54.15 (+3.34%)
BA   195.50 (-1.51%)
S&P 500   4,596.29 (-1.27%)
DOW   34,662.39 (-1.35%)
QQQ   394.40 (-1.32%)
AAPL   163.91 (+2.29%)
MSFT   331.43 (-1.54%)
FB   327.70 (-3.06%)
GOOGL   2,853.08 (-1.98%)
AMZN   3,514.53 (-1.32%)
TSLA   1,135.88 (-0.10%)
NVDA   323.96 (-2.94%)
BABA   127.48 (-3.14%)
NIO   39.14 (-3.26%)
CGC   10.48 (-5.24%)
AMD   157.48 (-2.74%)
GE   95.40 (-3.05%)
MU   85.01 (-1.31%)
T   22.68 (-5.06%)
F   19.24 (-2.19%)
DIS   144.18 (-2.46%)
ACB   6.24 (-3.11%)
AMC   34.13 (-7.36%)
PFE   54.15 (+3.34%)
BA   195.50 (-1.51%)
S&P 500   4,596.29 (-1.27%)
DOW   34,662.39 (-1.35%)
QQQ   394.40 (-1.32%)
AAPL   163.91 (+2.29%)
MSFT   331.43 (-1.54%)
FB   327.70 (-3.06%)
GOOGL   2,853.08 (-1.98%)
AMZN   3,514.53 (-1.32%)
TSLA   1,135.88 (-0.10%)
NVDA   323.96 (-2.94%)
BABA   127.48 (-3.14%)
NIO   39.14 (-3.26%)
CGC   10.48 (-5.24%)
AMD   157.48 (-2.74%)
GE   95.40 (-3.05%)
MU   85.01 (-1.31%)
T   22.68 (-5.06%)
F   19.24 (-2.19%)
DIS   144.18 (-2.46%)
ACB   6.24 (-3.11%)
AMC   34.13 (-7.36%)
PFE   54.15 (+3.34%)
BA   195.50 (-1.51%)
S&P 500   4,596.29 (-1.27%)
DOW   34,662.39 (-1.35%)
QQQ   394.40 (-1.32%)
AAPL   163.91 (+2.29%)
MSFT   331.43 (-1.54%)
FB   327.70 (-3.06%)
GOOGL   2,853.08 (-1.98%)
AMZN   3,514.53 (-1.32%)
TSLA   1,135.88 (-0.10%)
NVDA   323.96 (-2.94%)
BABA   127.48 (-3.14%)
NIO   39.14 (-3.26%)
CGC   10.48 (-5.24%)
AMD   157.48 (-2.74%)
GE   95.40 (-3.05%)
MU   85.01 (-1.31%)
T   22.68 (-5.06%)
F   19.24 (-2.19%)
DIS   144.18 (-2.46%)
ACB   6.24 (-3.11%)
AMC   34.13 (-7.36%)
PFE   54.15 (+3.34%)
BA   195.50 (-1.51%)
NASDAQ:APVO

Aptevo Therapeutics Institutional Ownership

$9.80
-0.73 (-6.93%)
(As of 11/30/2021 01:49 PM ET)
Add
Compare
Today's Range
$9.50
$11.27
50-Day Range
$6.48
$17.49
52-Week Range
$6.38
$51.75
Volume
107,010 shs
Average Volume
9.99 million shs
Market Capitalization
$48.02 million
P/E Ratio
N/A
Dividend Yield
N/A
Beta
6.74

Institutional Ownership Changes (13F Filings) for Aptevo Therapeutics (NASDAQ:APVO)

Current
Institutional Ownership
Percentage
96.53%

Number of
Institutional Buyers
(last 12 months)
23

Total
Institutional Inflows
(last 12 months)
$22.15 M

Number of
Institutional Sellers
(last 12 months)
8

Total
Institutional Outflows
(last 12 months)
$19.13 M

Skip Chart & View Institutional Buying and Selling Data

Institutional Buying and Selling by Quarter


Aptevo Therapeutics (NASDAQ APVO) Institutional Buying and Selling

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
11/15/2021Morgan Stanley11,028$0.17M0.0%+31.9%0.225%
11/15/2021Franklin Resources Inc.15,650$0.24M0.0%N/A0.320%
11/15/2021GSA Capital Partners LLP13,651$0.21M0.0%N/A0.279%
11/12/2021Renaissance Technologies LLC143,419$2.21M0.0%-10.3%2.931%
11/12/2021Geode Capital Management LLC39,924$0.62M0.0%+2.6%0.816%
11/9/2021BlackRock Inc.55,394$0.86M0.0%+1.9%1.133%
11/5/2021Moors & Cabot Inc.389,269$3.73M0.3%N/A7.954%
8/23/2021Morgan Stanley8,364$0.19M0.0%+163.4%0.171%
8/17/2021Balyasny Asset Management LLC18,012$0.40M0.0%-70.6%0.405%
8/17/2021Boothbay Fund Management LLC15,350$0.34M0.0%+4.9%0.345%
8/16/2021Alyeska Investment Group L.P.139,172$3.12M0.0%-80.9%3.127%
8/16/2021Morgan Stanley8,364$0.19M0.0%+163.4%0.188%
8/16/2021Kennedy Capital Management Inc.187,995$4.22M0.1%N/A4.225%
8/16/2021State Street Corp10,973$0.25M0.0%N/A0.247%
8/13/2021Renaissance Technologies LLC159,923$3.59M0.0%-23.6%3.594%
8/13/2021Anson Funds Management LP35,587$0.80M0.1%-26.6%0.800%
8/13/2021Northern Trust Corp22,652$0.51M0.0%+170.7%0.509%
8/13/2021QS Investors LLC15,650$0.35M0.0%+37.3%0.352%
8/13/2021Geode Capital Management LLC38,917$0.87M0.0%+8.8%0.875%
8/13/2021Vanguard Group Inc.134,760$3.02M0.0%+2.9%3.028%
5/17/2021Schonfeld Strategic Advisors LLC9,700$0.30M0.0%-12.6%0.218%
5/14/2021RTW Investments LP281,402$8.59M0.1%-2.4%6.324%
5/14/2021Dynamic Technology Lab Private Ltd14,022$0.43M0.0%+6.2%0.315%
5/13/2021QS Investors LLC11,400$0.35M0.0%N/A0.256%
5/13/2021JBF Capital Inc.3,907$0.12M0.0%+49.9%0.088%
5/13/2021Renaissance Technologies LLC209,223$6.39M0.0%-17.8%4.702%
5/13/2021Bank of New York Mellon Corp9,964$0.31M0.0%N/A0.224%
5/13/2021Bank of Montreal Can25,280$0.67M0.0%-20.1%0.568%
5/12/2021Geode Capital Management LLC35,762$1.09M0.0%+26.8%0.804%
5/7/2021BlackRock Inc.57,605$1.76M0.0%-1.0%1.294%
3/8/2021Dimensional Fund Advisors LP5,502$0.20M0.0%N/A0.126%
2/25/2021Dimensional Fund Advisors LP5,502$0.20M0.0%N/A0.126%
2/24/2021Alyeska Investment Group L.P.49,601$1.82M0.0%N/A1.133%
2/18/2021Ghost Tree Capital LLC50,000$1.83M0.4%N/A1.142%
2/16/2021Alyeska Investment Group L.P.49,601$1.82M0.0%N/A1.133%
2/16/2021Pura Vida Investments LLC8,203$0.30M0.0%N/A0.187%
2/16/2021Price T Rowe Associates Inc. MD6,300$0.23M0.0%N/A0.144%
2/12/2021Stonepine Capital Management LLC18,280$0.67M0.5%N/A0.417%
2/11/2021JBF Capital Inc.2,607$96K0.0%N/A0.060%
2/11/2021Northern Trust Corp8,707$0.32M0.0%N/A0.199%
2/11/2021Citigroup Inc.967$35K0.0%N/A0.022%
2/11/2021Dynamic Technology Lab Private Ltd13,202$0.48M0.1%N/A0.301%
2/10/2021Renaissance Technologies LLC254,423$9.33M0.0%-13.1%5.810%
2/9/2021Wells Fargo & Company MN1,552$57K0.0%+241.1%0.035%
2/5/2021BlackRock Inc.58,168$2.13M0.0%+166.8%1.328%
11/16/2020Worth Venture Partners LLC27,645$0.21M0.2%-21.8%0.667%
11/9/2020Acadian Asset Management LLC45,126$0.34M0.0%-2.5%1.396%
11/6/2020GSA Capital Partners LLP40,512$0.31M0.1%N/A1.253%
8/5/2020WINTON GROUP Ltd11,332$95K0.0%N/A0.351%
7/31/2020UBS Group AG10,015$83K0.0%-13.3%0.310%
5/1/2020BlackRock Inc.21,968$81K0.0%-92.8%0.679%
5/1/2020UBS Group AG11,548$43K0.0%-93.4%0.358%
2/14/2020Bank of New York Mellon Corp56,181$37K0.0%-44.2%0.124%
2/14/2020UBS Group AG175,092$0.12M0.0%+27.3%0.387%
2/13/2020Renaissance Technologies LLC2,379,859$1.56M0.0%+9.8%5.256%
11/27/2019Point72 Asset Management L.P.2,450,000$1.44M0.0%+4.3%5.411%
8/14/2019Point72 Asset Management L.P.2,350,000$2.08M0.0%+6.8%5.211%
8/14/2019Worth Venture Partners LLC447,669$0.40M0.2%+4.4%0.993%
8/14/2019Algert Global LLC74,906$66K0.0%N/A0.166%
8/14/2019Vanguard Group Inc.1,122,138$0.99M0.0%-24.5%2.489%
8/14/2019A.R.T. Advisors LLC131,134$0.12M0.0%+203.5%0.291%
8/13/2019Stonepine Capital Management LLC3,922,891$3.48M2.4%+0.7%8.700%
8/13/2019BlackRock Inc.305,365$0.27M0.0%-13.7%0.677%
8/12/2019Renaissance Technologies LLC1,644,856$1.46M0.0%+32.9%3.648%
8/12/2019Bank of New York Mellon Corp56,620$50K0.0%+256.3%0.126%
8/8/2019Acadian Asset Management LLC632,507$0.56M0.0%+312.8%1.403%
6/16/2019Marshall Wace LLP36,569$33K0.0%N/A0.081%
4/1/2019Deutsche Bank AG330,200$0.42M0.0%+251.7%0.769%
2/14/2019Park West Asset Management LLC165,520$0.21M0.0%-66.9%0.726%
2/13/2019Dimensional Fund Advisors LP1,442,049$1.83M0.0%+1.2%6.323%
2/13/2019Clifford Swan Investment Counsel LLC27,200$35K0.0%N/A0.119%
2/7/2019Acadian Asset Management LLC462,824$0.59M0.0%+4.8%2.029%
11/15/2018Sessa Capital IM L.P.706,613$3.59M0.5%+35.9%3.117%
11/13/2018Renaissance Technologies LLC1,277,100$6.49M0.0%+11.1%5.633%
11/13/2018Dimensional Fund Advisors LP1,425,567$7.24M0.0%+5.5%6.288%
11/13/2018Alambic Investment Management L.P.70,517$0.36M0.3%-39.4%0.311%
11/7/2018JPMorgan Chase & Co.76,339$0.39M0.0%-73.7%0.337%
10/30/2018Acadian Asset Management LLC441,765$2.24M0.0%+20.2%1.949%
9/18/2018Northern Trust Corp70,416$0.35M0.0%+21.2%0.311%
8/14/2018Alambic Investment Management L.P.116,427$0.58M0.2%-41.1%0.514%
8/13/2018Renaissance Technologies LLC1,149,400$5.74M0.0%+53.3%5.088%
8/10/2018Dimensional Fund Advisors LP1,351,656$6.75M0.0%+10.8%5.983%
8/3/2018EAM Investors LLC110,584$0.55M0.1%N/A0.490%
8/2/2018Connor Clark & Lunn Investment Management Ltd.29,650$0.15M0.0%N/A0.131%
7/24/2018Acadian Asset Management LLC367,509$1.83M0.0%+79.0%1.627%
5/16/2018Millennium Management LLC96,891$0.32M0.0%-54.9%0.429%
5/15/2018Park West Asset Management LLC184,629$0.60M0.0%N/A0.817%
5/11/2018Citadel Advisors LLC39,653$0.13M0.0%+215.4%0.177%
5/11/2018Dimensional Fund Advisors LP1,219,852$3.99M0.0%+11.2%5.436%
5/10/2018JPMorgan Chase & Co.254,282$0.83M0.0%+346.6%1.133%
5/10/2018Spark Investment Management LLC129,400$0.42M0.0%+82.8%0.577%
5/8/2018Alambic Investment Management L.P.197,617$0.65M0.1%N/A0.881%
5/4/2018Victory Capital Management Inc.215,110$0.70M0.0%+10.3%0.959%
2/15/2018Millennium Management LLC214,782$0.91M0.0%-28.4%1.002%
2/14/2018Sessa Capital IM L.P.1,628,053$6.90M0.8%-15.2%7.594%
2/13/2018Renaissance Technologies LLC428,400$1.82M0.0%+411.8%1.998%
2/12/2018Spark Investment Management LLC70,800$0.30M0.0%-34.5%0.330%
2/9/2018Virtu Financial LLC162,689$0.69M0.0%N/A0.759%
2/9/2018BlackRock Inc.350,913$1.49M0.0%-33.0%1.637%
2/1/2018Victory Capital Management Inc.195,110$0.83M0.0%N/A0.910%
(Data available from 1/1/2016 forward)













Aptevo Therapeutics (NASDAQ:APVO) Institutional Ownership Frequently Asked Questions

Who are the institutional owners of Aptevo Therapeutics?

During the previous two years, 33 institutional investors and hedge funds held shares of Aptevo Therapeutics. The most heavily invested institutionals were RTW Investments LP ($8.59M), Kennedy Capital Management Inc. ($4.22M), Moors & Cabot Inc. ($3.73M), Alyeska Investment Group L.P. ($3.12M), Vanguard Group Inc. ($3.02M), Renaissance Technologies LLC ($2.21M), and Ghost Tree Capital LLC ($1.83M).Learn more on APVO's institutional investors

What percentage of Aptevo Therapeutics stock is owned by institutional investors?

96.53% of Aptevo Therapeutics stock is owned by institutional investors. Learn more on APVO's institutional investor holdings

Which institutional investors have been buying Aptevo Therapeutics stock?

Of the 26 institutional investors that purchased Aptevo Therapeutics stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Moors & Cabot Inc. ($0.39M), Renaissance Technologies LLC ($0.21M), Kennedy Capital Management Inc. ($0.19M), Alyeska Investment Group L.P. ($99.20K), GSA Capital Partners LLP ($54.16K), Ghost Tree Capital LLC ($50K), and UBS Group AG ($37.55K).

How much institutional buying is happening at Aptevo Therapeutics?

Institutional investors have bought a total of 1,247,725 shares in the last 24 months. This purchase volume represents approximately $22.71M in transactions.

Which Aptevo Therapeutics institutionals have been selling company stock?

Of the 12 institutional investors that sold Aptevo Therapeutics stock in the last 24 months, the following investors and hedge funds have sold the highest volume of shares: Alyeska Investment Group L.P. ($0.59M), BlackRock Inc. ($0.29M), UBS Group AG ($0.17M), Renaissance Technologies LLC ($0.15M), Bank of New York Mellon Corp ($44.46K), Balyasny Asset Management LLC ($43.32K), and Anson Funds Management LP ($12.92K).

How much institutional selling is happening at Aptevo Therapeutics?

Institutional investors have sold a total of 1,314,770 shares in the last 24 months. This volume of shares sold represents approximately $20.89M in transactions.

This page was last updated on 11/30/2021 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.